A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache
NCT ID: NCT06132529
Last Updated: 2025-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
151 participants
OBSERVATIONAL
2019-06-03
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate White Matter Hyperintensities in Migraine
NCT05112289
MRA/fMRI Study of Spontaneous Migraine
NCT01471314
EEG Diagnostic for Repetitive Sub-concussive Head Impacts
NCT05562544
Brain Biomarkers w/Mind-Body Tx in Veterans With Post Traumatic Headache (PTH)
NCT02145117
Imaging of Traumatic Brain Injury
NCT01196299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post-Traumatic Headache Group
Subjects diagnosed with having post-traumatic headache complete an MRI, speech sample, and electronic daily headache diary.
Brain Magnetic Resonance Imaging (MRI) Scan
Imaging of the brain
Speech Sample
Recorded reading aloud of pre-written words and sentences
Electronic Daily Headache Diary
Headache diary to provide information about headaches experience that day.
Healthy Control Group
Subjects identified as health and not having any headaches will complete an MRI and speech sample.
Brain Magnetic Resonance Imaging (MRI) Scan
Imaging of the brain
Speech Sample
Recorded reading aloud of pre-written words and sentences
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brain Magnetic Resonance Imaging (MRI) Scan
Imaging of the brain
Speech Sample
Recorded reading aloud of pre-written words and sentences
Electronic Daily Headache Diary
Headache diary to provide information about headaches experience that day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For patients with PTH, only patients with new onset of PTH without history of PPTH will be included in the study.
* A personal history of prior concussion and history of migraine are allowed according to ICHD-III diagnostic criteria.
* Tension-type headaches on three or fewer days per month is allowed for healthy control subjects.
Exclusion Criteria
* Prior history of gross anatomical change on imaging.
* Contraindication to MRI, including but not limited to severe claustrophobia and/or presence of ferrous materials in the body.
* Women who are pregnant, or believe that they might be pregnant. Although there are no known contraindications or risks associated with pregnancy and MRI, we will exclude pregnant women or women who believe that there might be a chance that they are pregnant.
* History of concussion or more severe TBI.
* History of migraine or other headaches.
* The diagnosis for PTH and PPTH will be verified by Dr. Schwedt (co-investigator) a board-certified physician in Neurology and Headache Medicine. Presence of concussion will be verified using the Ohio State University TBI Identification Method, a standardized questionnaire assessing the lifetime history of TBI for an individual.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Arizona State University
OTHER
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Catherine (Cat) Chong
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine Chong, PhD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Health Care System
Phoenix, Arizona, United States
Mayo Clinic Arizona
Phoenix, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-005203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.